Table 2.
Features of patients who suffered IHCA in the two New York City based hospitals compared with all other study hospitals.
| Non-NYC | NYC | p-Value | ||
|---|---|---|---|---|
| n = 56 | n = 204 | |||
| Age, median (IQR) | 63 (54–73) | 70 (63–79) | <0.001 | |
| Gender | Male | 35 (62.5%) | 151 (74.0%) | 0.09 |
| Race/ethnicity: | Black | 18 (32.1%) | 26 (12.7%) | <0.001 |
| Hispanic | 9 (16.1%) | 33 (16.2%) | ||
| White | 16 (28.6%) | 113 (55.4%) | ||
| Other | 8 (14.3%) | 30 (14.7%) | ||
| Unknown | 5 (8.9%) | 2 (1.0%) | ||
| Pre-IHCA conditions | Sepsis | 19 (33.9%) | 84 (41.2%) | 0.33 |
| Hypotension | 23 (41.1%) | 101 (49.5%) | 0.26 | |
| Metastatic/haematological malignancy | 1 (1.8%) | 8 (3.9%) | 0.44 | |
| Hepatic insufficiency | 7 (12.5%) | 4 (2.0%) | <0.001 | |
| Renal insufficiency | 21 (37.5%) | 106 (52.0%) | 0.06 | |
| Location of cardiac arrest | Non-ICU | 12 (21.4%) | 82 (40.2%) | 0.01 |
| ICU | 44 (78.6%) | 122 (59.8%) | ||
| Initial rhythm | VF | 4 (7.1%) | 3 (1.5%) | <0.001 |
| pVT | 4 (7.1%) | 11 (5.4%) | ||
| PEA | 41 (73.2%) | 76 (37.3%) | ||
| Asystole | 7 (12.5%) | 109 (53.4%) | ||
| Unknown | 0 (0.0%) | 5 (2.5%) | ||
| IHCA outcomes | Sustained ROSC | 36 (64.3%) | 22 (10.8%) | <0.001 |
| Thirty day survival | 20 (35.7%) | 12 (5.9%) | <0.001 |
Abbreviations: CCU: cardiac/coronary care unit; CPAP: continuous positive pressure ventilation; CPC: cerebral performance category; HHFNC: heated high flow nasal cannula; ICU: intensive care unit; IHCA: in-hospital cardiac arrest; NC: nasal cannula; NIV: non-invasive ventilation; NRB: non-rebreathe mask; PEA: pulseless electrical activity; pVT: pulseless ventricular tachycardia; ROSC: return of spontaneous circulation; VF: ventricular fibrillation.